文献速递肝病

加拿大原发性胆汁性胆管炎患者的种族、疾病严重程度与生存

Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis.
PubMed 文献 · Hepatology · 2022-03-15

研究纳入加拿大六个中心1538例原发性胆汁性胆管炎患者,比较不同种族间生存与疾病严重程度。原住民患者肝移植无生存期和事件无生存期均较白人患者差(HR 3.66和3.09),诊断前发生临床事件比例更高(10%),且碱性磷酸酶、总胆红素和GLOBE评分更高,随访中持续升高。

要点

  • 原住民患者肝移植无生存期较白人患者差(HR 3.66,95%CI 2.23-6.01)。
  • 原住民患者事件无生存期较白人患者差(HR 3.09,95%CI 1.94-4.92)。
  • 原住民患者诊断前临床事件比例10%,高于其他所有种族。

核心结论

  • 加拿大原住民原发性胆汁性胆管炎患者就诊时疾病已进展,长期结局较白人患者差。

研究设计与样本

  • 来自加拿大自身免疫性肝病网络六个中心的1538例原发性胆汁性胆管炎患者队列。
  • 种族按加拿大统计局修改列表定义,小样本种族合并。
  • 临床事件定义为肝失代偿、肝细胞癌、肝移植或死亡。
  • 采用Cox回归分析临床事件无生存期和肝移植无生存期。

主要发现

  • 队列种族构成:白人82%、原住民4.7%、东亚裔5.5%、南亚裔2.6%、其他5.1%。
  • 原住民患者肝移植无生存期较白人患者差(HR 3.66;95%CI 2.23-6.01)。
  • 原住民患者事件无生存期较白人患者差(HR 3.09;95%CI 1.94-4.92)。
  • 原住民患者诊断前发生临床事件比例10%,高于其他所有种族,尽管诊断年龄相似。
  • 原住民患者碱性磷酸酶、总胆红素和GLOBE评分高于白人患者,随访期间相对升高持续存在。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: We investigated associations between ethnicity, survival, and disease severity in a diverse Canadian cohort of patients with primary biliary cholangitis (PBC). APPROACH AND RESULTS: Patients with PBC were included from the Canadian Network for Autoimmune Liver Disease. Ethnicity was defined using a modified list adopted from Statistics Canada, and ethnicities with small samples were grouped. Clinical events were defined as liver decompensation, HCC, liver transplantation, or death. Clinical event-free and liver transplantation-free survival were analyzed using Cox regression. Trajectories of serum liver function tests were assessed over time using mixed-effects regression. Health-related quality of life was assessed using the Short Form 36, the PBC-40 questionnaire, and the 5-D Itch scale and analyzed using mixed-effects regression. The cohort included 1538 patients with PBC from six sites and was comprised of 82% White, 4.7% Indigenous, 5.5% East Asian, 2.6% South Asian, and 5.1% miscellaneous ethnicities. Indigenous patients were the only ethnic group with impaired liver transplant-free and event-free survival compared to White patients (HR, 3.66; 95% CI, 2.23-6.01; HR, 3.09; 95% CI, 1.94-4.92). Indigenous patients were more likely to have a clinical event before diagnosis (10%) than all other ethnic groups despite similar age at diagnosis. Indigenous patients presented with higher alkaline phosphatase, total bilirubin, and GLOBE scores than White patients; and these relative elevations persisted during follow-up. CONCLUSIONS: Indigenous Canadians with PBC present with advanced disease and have worse long-term outcomes compared to White patients.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Roberts SB, Hirschfield GM, Worobetz LJ, et al. Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis. Hepatology. 2022. PMID: 35220609. doi:10.1002/hep.32426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。